JP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Recommandations pour la prévention, le diagnostic et la thérapie des addictions à l’âge avancé | Revue médicale suisse | 2022 | 54 | 268 | |||
| Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies | Frontiers in aging neuroscience | 2021 | 89 | 124 | |||
| Relationship between delirium and depression in old age | Swiss archives of neurology, psychiatry and psychotherapy | 2021 | 316 | 427 | |||
| Empfehlungen für die Prävention, Diagnostik und Therapie der Abhängigkeitserkrankungen im Alter | Praxis | 2021 | 40 | 0 | |||
| Replication study of plasma proteins relating to Alzheimer's pathology | Alzheimer's & dementia | 2021 | 218 | 149 | |||
| A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort | Alzheimer's & dementia | 2019 | 477 | 242 | |||
| Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay | Alzheimer's & Dementia | 2019 | 334 | 325 | |||
| Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort | Alzheimer's & Dementia | 2019 | 309 | 269 | |||
| Preoperative Depression and Plasma Cortisol Levels as Predictors of Delirium after Cardiac Surgery | Dementia and geriatric cognitive disorders | 2019 | 205 | 0 | |||
| The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research and Therapy | 2018 | 498 | 0 | |||
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease | Alzheimer's & Dementia | 2018 | 460 | 3 | |||
| Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive impairment? | Neurobiology of Aging | 2018 | 450 | 0 | |||
| MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study | Alzheimer's Research and Therapy | 2018 | 482 | 373 | |||
| Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia | Praxis (Bern 1994) | 2018 | 577 | 0 | |||
| A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects | Analytica Chimica Acta | 2018 | 471 | 1 | |||
| Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia | JAMA Psychiatry | 2018 | 533 | 416 | |||
| The Effects of Hand Massage on Stress and Agitation Among People with Dementia in a Hospital Setting: A Pilot Study | Applied Psychophysiology and Biofeedback | 2018 | 482 | 571 | |||
| Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization | Journal of Alzheimer's Disease | 2017 | 790 | 0 | |||
| Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease | Alzheimer's & Dementia | 2017 | 412 | 0 | |||
| Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based Study | Frontiers in Aging Neuroscience | 2017 | 430 | 281 | |||
| Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia | Journal of Alzheimer's Disease | 2017 | 471 | 0 | |||
| ICP-MS/MS-Based Ionomics: A Validated Methodology to Investigate the Biological Variability of the Human Ionome | Journal of Proteome Research | 2017 | 430 | 1 | |||
| Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults | Journal of Alzheimer's Disease | 2017 | 443 | 0 | |||
| Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology | Journal of Psychiatric Research | 2017 | 785 | 1 | |||
| Life events, salivary cortisol, and cognitive performance in nondemented subjects: a population-based study | Neurobiology of Aging | 2017 | 443 | 2 | |||
| One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond | Alzheimer's Research and Therapy | 2017 | 549 | 247 | |||
| Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia | Experimental Gerontology | 2017 | 416 | 0 | |||
| Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study | Neurology | 2017 | 1,069 | 1 | |||
| Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults | Brain, Behavior and Immunity | 2017 | 455 | 0 | |||
| Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance | Alzheimer's Research and Therapy | 2017 | 448 | 190 | |||
| Response to a letter to the editor: sleep disturbance as a stressor event in elderly's life | Neurobiology of Aging | 2017 | 408 | 0 | |||
| L'agitation chez les personnes atteintes de démence : examen de la portée des connaissances et mise en perspective du phénomène selon la théorie du confort et le concept de l'attachement | Recherche en soins infirmiers | 2016 | 573 | 0 | |||
| Les biomarqueurs du liquide céphalorachidien dans la maladie d'Alzheimer en pratique clinique courante | Revue médicale suisse | 2016 | 473 | 318 | |||
| Recommandations for prevention, diagnostic and therapy of delirium in the elderly | Praxis (Bern 1994) | 2016 | 433 | 0 | |||
| Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta | Journal of Neurochemistry | 2016 | 449 | 0 | |||
| Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study | International Psychogeriatrics | 2015 | 443 | 0 | |||
| Delirium in the elderly: Current problems with increasing geriatric age | Indian Journal of Medical Research | 2015 | 424 | 550 | |||
| CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study | Alzheimer's and Dementia | 2015 | 421 | 0 | |||
| Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type | Neurobiology of Aging | 2015 | 442 | 0 | |||
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | JAMA | 2015 | 614 | 2 | |||
| Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD) | Praxis (Bern 1994) | 2014 | 567 | 0 | |||
| Subjective cognitive decline in patients with mild cognitive impairment and healthy older adults: association with personality traits | Geriatrics and Gerontology International | 2014 | 397 | 2 | |||
| SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease | Human Molecular Genetics | 2014 | 395 | 1 | |||
| Predisposing and precipitating factors of delirium after cardiac surgery: a prospective observational cohort study | Annals of Surgery | 2013 | 421 | 0 | |||
| The evolution of personality in patients with mild cognitive impairment | Dementia and Geriatric Cognitive Disorders | 2013 | 428 | 0 | |||
| Delirium and cognitive decline: more than a coincidence | Current Opinion in Neurology | 2013 | 343 | 0 | |||
| Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease | Biochemical Pharmacology | 2013 | 443 | 0 | |||
| Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial | The Lancet Neurology | 2013 | 357 | 0 |
